James Blankenship, MD
Interventional Cardiology · Albuquerque, NMNPI 1386619575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Boston Scientific at 30.6% of the total. That places this record below the midpoint for interventional cardiology clinicians in NM, where the typical reported total is $6,781.
Across 36 payments — averaging $43.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$475
- Abiomed$384
- Medtronic$119
- Edwards Lifesciences$105
- Stryker$99
- Cardiovascular Systems Inc.$96
- plus $274 from 7 others
Across 122 payments — averaging $6396.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Circulation Inc$760K
- Abbott$16K
- Boston Scientific$4K
What the payments were for
- Food & beverage$1,551100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $475 |
| Abiomed | 9 | $384 |
| Medtronic(2 entities) | 4 | $119 |
| Edwards Lifesciences | 1 | $105 |
| Stryker | 1 | $99 |
| Cardiovascular Systems Inc. | 1 | $96 |
| Abbott | 1 | $76 |
| Philips North America LLC | 3 | $66 |
| Biosense Webster, Inc. | 2 | $61 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Teleflex LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,551 in reported general payments places this provider in the 25th percentile of 25 interventional cardiology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $24,934 |
| Losartan Potassium | 42 | $611 |
| Atorvastatin Calcium | 31 | $359 |
| Amlodipine Besylate | 24 | $271 |
| Metoprolol Tartrate | 28 | $228 |
| Ezetimibe | 15 | $224 |
| Lisinopril | 26 | $188 |
| Metoprolol Succinate | 16 | $171 |
| Carvedilol | 15 | $105 |
| Furosemide | 13 | $69 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Albuquerque
- Mark BieniarzAlbuquerque$207K
- Raymond YauAlbuquerque$171K
- Robert FedericiAlbuquerque$77K
- Sharif HalimAlbuquerque$22K
- Geoffrey KunzAlbuquerque$22K
- Charles KimAlbuquerque$9K
- Harvey WhiteAlbuquerque$3K
- Guilherme MarinAlbuquerque$3K
- John BattyAlbuquerque$82
- Abdul KhanLas Cruces$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.